Induction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes

Journal of Immunology

Volumn 181, Issue 12, 2008, Pages 8323-8334

  Karumuthil Melethil, Subha ^a   Perez, Nicolas ^a   Li, Ruobing ^a   Vasu, Chenthamarakshan ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; DECTIN 1; INTERLEUKIN 10; INTERLEUKIN 2; L SELECTIN; TOLL LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN; CYTOKINE; MEMBRANE PROTEIN; NERVE PROTEIN; TLR2 PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEVELOPED COUNTRY; FEMALE; HYGIENE; HYPERGLYCEMIA; INFECTION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; COCULTURE; CROSS BREEDING; GENETICS; HYPERINSULINISM; IMMUNOLOGY; IMPAIRED GLUCOSE TOLERANCE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELLS, CULTURED; COCULTURE TECHNIQUES; CROSSES, GENETIC; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; HYPERGLYCEMIA; HYPERINSULINISM; IMMUNITY, INNATE; MEMBRANE PROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; NERVE TISSUE PROTEINS; PREDIABETIC STATE; TOLL-LIKE RECEPTOR 2; ZYMOSAN;

EID: 58849145188     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.12.8323     Document Type: Article

References (72)

1. Jahromi, M. M., and G. S. Eisenbarth. 2007. Cellular and molecular pathogenesis of type 1A diabetes. Cell Mol. Life Sci. 64: 865-872.
2. Gale, E. A. M. 2002. The rise of childhood type 1 diabetes in the 20th century. Diabetes 51: 3353-3361.
3. Bodansky, H. J., A. Staines, C. Stephenson, D. Haigh, and R. Cartwright. 1992. Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population. Br. Med. J. 304: 1020-1022.
4. van den Berg, T. K., J. A. Yoder, and G. W. Litman. 2004. On the origins of adaptive immunity: innate immune receptors join the tale. Trends Immunol. 25: 11-16. (Pubitemid 38032803)
5. Roy, C. R., and E. S. Mocarski. 2007. Pathogen subversion of cell-intrinsic innate immunity. Nat. Immunol. 8: 1179-1187.
6. Albiger, B., S. Dahlberg, B. Henriques-Normark, and S. Normark. 2007. Role of the innate immune system in host defense against bacterial infections: focus on the Toll-like receptors. J. Intern. Med. 261: 511-528. (Pubitemid 46835986)
7. Belardelli, F., and M. Ferrantini. 2002. Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol. 23: 201-208. (Pubitemid 34260936)
8. Moriyama, H., L. Wen, N. Abiru, E. Liu, L. Yu, D. Miao, R. Gianani, F. S. Wong, and G. S. Eisenbarth. 2002. Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin selfpeptide. Proc. Natl. Acad. Sci. USA 99: 5539-5544.
9. Kim, H. S., M. S. Han, K. W. Chung, S. Kim, E. Kim, M. J. Kim, E. Jang, H. A. Lee, J. Youn, S. Akira, and M. S. Lee. 2007. Toll-like receptor 2 senses β-cell death and contributes to the initiation of autoimmune diabetes. Immunity 27: 321-333.
10. Lang, K. S., M. Recher, T. Junt, A. A. Navarini, N. L. Harris, S. Freigang, B. Odermatt, C. Conrad, L. M. Ittner, S. Bauer, et al. 2005. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat. Med. 11: 138-145.
11. + interferon-γ-induced apoptosis in primary pancreatic β-cells. J. Biol. Chem. 280: 33984-33991.
12. Dogusan, Z., M. García, D. Flamez, L. Alexopoulou, M. Goldman, C. Gysemans, C. Mathieu, C. Libert, D. L. Eizirik, and J. Rasschaert. 2008. Double-stranded RNA induces pancreatic β cell apoptosis by activation of the TLR3 and IRF-3 pathways. Diabetes 57: 1236-1245.
13. + regulatory T cells in the islets in non-obese diabetic mice. Biochem. Biophys. Res. Commun. 367: 719-724.
14. Lien, E., T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, and D. T. Golenbock. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274: 33419-33425. (Pubitemid 129511647)
15. Ozinsky, A., D. M. Underhill, J. D. Fontenot, A. M. Hajjar, K. D. Smith, C. B. Wilson, L. Schroeder, and A. Aderem. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. USA 97: 13766-13771.
16. Lee, J. Y., L. Zhao, H. S. Youn, A. R. Weatherill, R. Tapping, L. Feng, W. H. Lee, K. A. Fitzgerald, and D. H. Hwang. 2004. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J. Biol. Chem. 279: 16971-16979.
17. Takeda, K., O. Takeuchi, and S. Akira. 2002. Recognition of lipopeptides by Toll-like receptors. J. Endotoxin Res. 8: 459-463.
18. Omueti, K. O., J. M. Beyer, C. M. Johnson, E. A. Lyle, and R. I. Tapping. 2005. Domain exchange between human Toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination. J. Biol. Chem. 280: 36616-36625.
19. Buwitt-Beckmann, U., H. Heine, K. H. Wiesmuller, G. Jung, R. Brock, S. Akira, and A. J. Ulmer. 2005. TLR1- and TLR6-independent recognition of bacterial lipopeptides. J. Biol. Chem. 281: 9049-9057.
20. Buwitt-Beckmann, U., H. Heine, K. H. Wiesmuller, G. Jung, R. Brock, S. Akira, and A. J. Ulmer. 2005. Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur. J. Immunol. 35: 282-289. (Pubitemid 40123875)
21. Farhat, K., S. Riekenberg, H. Heine, J. Debarry, R. Lang, J. Mages, U. Buwitt-Beckmann, K. Roschmann, G. Jung, K. H. Wiesmuller, and A. J. Ulmer. 2008. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J. Leukocyte Biol. 83: 692-701. (Pubitemid 351966879)
22. Sing. A., D. Reithmeier-Rost, K. Granfors, J. Hill, A. Roggenkamp, and J. Heesemann. 2005. A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence. Proc. Natl. Acad. Sci. USA 102: 16049-16054. (Pubitemid 41552865)
23. Kiura, K., H. Kataoka, M. Yasuda, N. Inoue, and K. Shibata. 2006. The diacylated lipopeptide FSL-1 induces TLR2-mediated Th2 responses. FEMS Immunol. Med. Microbiol. 48: 44-55. (Pubitemid 44379219)
24. Martin, M., R. E. Schifferle, N. Cuesta, S. N. Vogel, J. Katz, and S. M. Michalek. 2003. Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. J. Immunol. 171: 717-725. (Pubitemid 36871381)
25. Polumuri, S. K., V. Y. Toshchakov, and S. N. Vogel. 2007. Role of phosphatidylinositol-3 kinase in transcriptional regulation of TLR-induced IL-12 and IL-10 by Fcγ receptor ligation in murine macrophages. J. Immunol. 179: 236-246.
26. + regulatory T cell function via innate TLR2 signaling. J. Clin. Invest. 116: 2022-2032. (Pubitemid 44033326)
27. + regulatory T cells. Proc. Natl. Acad. Sci. USA 103: 7048-7053.
28. Sutmuller, R. P., M. H. Den Brok, M. Kramer, E. J. Bennink, L. W. Toonen, B. J. Kullberg, L. A. Joosten, S. Akira, M. G. Netea, and G. J. Adema. 2006. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116: 485-494.
29. Goodridge, H. S., and D. M. Underhill. 2008. Fungal recognition by TLR2 and dectin-1. Handb. Exp. Pharmacol. 183: 87-109.
30. Underhill, D. M. 2007. Collaboration between the innate immune receptors dectin-1, TLRs, and nods. Immunol. Rev. 219: 75-87.
31. Dillon. S., S. Agrawal, K. Banerjee, J. Letterio, T. L. Denning, K. Oswald-Richter, D. J. Kasprowicz, K. Kellar, J. Pare, et al. 2006. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest. 116: 916-928.
32. Slack, E. C., M. J. Robinson, P. Hernanz-Falcón, G. D. Brown, D. L. Williams, E. Schweighoffer, V. L. Tybulewicz, and C. Reis e Sousa. 2007. Syk-dependent ERK activation regulates IL-2 and IL-10 production by DC stimulated with zymosan. Eur. J. Immunol. 37: 1600-1612.
33. Li, R., N. Perez, S. Karumuthil-Melethil, and C. Vasu. 2007. Bone marrow is a preferential homing site for autoreactive T-cells in type 1 diabetes. Diabetes 56: 2251-2259.
34. Savinov. A. Y., F. S. Wong, and A. V. Chervonsky. 2001. IFN-γ affects homing of diabetogenic T cells. J. Immunol. 167: 6637-6643.
35. Yadav, D., V. Judkowski, M. Flodstrom-Tullberg, L. Sterling, W. L. Redmond, L. Sherman, and N. Sarvetnick. 2004. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets. J. Immunol. 173: 3631-3639. (Pubitemid 39280722)
36. + T cells that prevent diabetes onset in nonobese diabetic mice. J. Immunol. 164: 240-247.
37. + regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA 101(Suppl. 2): 14580-14585.
38. + regulatory T-cells in type 1 diabetes. Diabetes 56: 604-612. (Pubitemid 46348451)
39. + T-cells in type 1 diabetes. Diabetes 54: 1407-1414.
40. Barr, T. A., S. Brown, G. Ryan, J. Zhao, and D. Gray. 2007. TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells. Eur. J. Immunol. 37: 3040-3053. (Pubitemid 350131284)
41. Mazzoni, A., and D. M. Segal. 2004. Controlling the Toll road to dendritic cell polarization. J. Leukocyte Biol. 75: 721-730. (Pubitemid 38580050)
42. Christen, U., T. Wolfe, U. Möhrle, A. C. Hughes, E. Rodrigo, E. A. Green, R. A. Flavell, and M. G. von Herrath. 2001. A dual role for TNF-α in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J. Immunol. 166: 7023-7032. (Pubitemid 32525571)
43. + T cell levels in NOD mice. Proc. Natl. Acad. Sci. USA 99: 12287-12292.
44. Lee, L. F., B. Xu, S. A. Michie, G. F. Beilhack, T. Warganich, S. Turley, and H. O. McDevitt. 2005. The role of TNF-α in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation. Proc. Natl. Acad. Sci. USA 102: 15995-16000.
45. + regulatory T cells. J. Exp. Med. 201: 1061-1067. (Pubitemid 40524674)
46. Zheng, X. X., A. W. Steele, W. W. Hancock, A. C. Stevens, P. W. Nickerson, P. Roy-Chaudhury, Y. Tian, and T. B. Strom. 1997. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. J. Immunol. 158: 4507-4513.
47. + regulatory T cells is antigen-specific and requires IL-10 and TGF-β. J. Immunol. 175: 4283-4291. (Pubitemid 41361962)
48. Fontenot, J. D., J. P. Rasmussen, M. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151.
49. Tang, Q., J. Y. Adams, C. Panaranda, K. Melli, E. Piaggio, E. Sgouroudis, C. A. Piccirillo, B. L. Salomon, and J. A. Bluestone. 2008. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28: 687-697.
50. Gantner, B. N., R. M. Simmons, S. J. Canavera, S. Akira, and D. M. Underhill. 2003. Collaborative induction of inflammatory responses by dectin-1 and Tolllike receptor 2. J. Exp. Med. 197: 1107-1117.
51. + T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes 42: 44-55.
52. Friedline, R. H., C. P. Wong, D. A. Steeber, T. F. Tedder, and R. Tisch. 2002. L-Selectin is not required for T cell-mediated autoimmune diabetes. J. Immunol. 168: 2659-2666.
53. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169: 2461-2465.
54. Bingaman, A. W., D. S. Patke, V. R. Mane, M. Ahmadzadeh, M. Ndejembi, S. T. Bartlett, and D. L. Farber. 2005. Novel phenotypes and migratory properties distinguish memory CD4 T cell subsets in lymphoid and lung tissue. Eur. J. Immunol. 35: 3173-3186.
55. - memory T cells do not differ in immediate effector cell function. J. Immunol. 169: 638-641.
56. + T cell memory by promoting the generation of IL-7R α-expressing cells. J. Exp. Med. 204: 547-557.
57. + regulatory T cells. J. Exp. Med. 199: 303-313. (Pubitemid 38252043)
58. + T cell regulatory functions. J. Immunol. 178: 271-279.
59. Bellelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 441: 235-238.
60. + effector T cells. J. Immunol. 176: 7278-7287.
61. Cools, N., P. Ponsaerts, V. F. Van Tendeloo, and Z. N. Berneman. 2007. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. J. Leukocyte Biol. 82: 1365-1374. (Pubitemid 350276946)
62. Kukreja, A., G. Cost, J. Marker, C. Zhang, Z. Sun, K. Lin-Su, S. Ten, M. Sanz, M. Exley, B. Wilson, et al. 2002. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109: 131-140. (Pubitemid 34052549)
63. + T-cell-mediated regulation and type 1 diabetes development in NOD mice. Diabetes 55: 2098-2105. (Pubitemid 44509985)
64. Kabelitz, D. 2007. Expression and function of Toll-like receptors in T lymphocytes. Curr. Opin. Immunol. 19: 39-45. (Pubitemid 46084902)
65. Xu, D., H. Liu, and M. Komai-Koma. 2004. Direct and indirect role of Toll-like receptors in T cell mediated immunity. Cell. Mol. Immunol. 1: 239-246.
66. Feillet, H., and J. F. Bach. 2004. On the mechanisms of the protective effect of infections on type 1 diabetes. Clin. Dev. Immunol. 11: 191-194. (Pubitemid 39423297)
67. Harada, M., Y. Kishimoto, and S. Makino. 1990. Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res. Clin. Pract. 8: 85-89. (Pubitemid 20034055)
68. Bras, A., and A. P. Aguas. 1996. Diabetes-prone NOD mice are resistant to Mycobacterium avium and the infection prevents autoimmune disease. Immunology 89: 20-25. (Pubitemid 26284033)
69. Toyota, T., J. Satoh, K. Oya, S. Shintani, and T. Okano. 1986. Streptococcal preparation (OK-432) inhibits development of type I diabetes in NOD mice. Diabetes 35: 496-499. (Pubitemid 16078466)
70. Ryu, S., S. Kodama, K. Ryu, D. A. Schoenfeld, and D. L. Faustman. 2001. Reversal of established autoimmune diabetes by restoration of endogenous β cell function. J. Clin. Invest. 108: 63-72.
71. Yadav, M., and J. S. Schorey. 2006. The β-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood 108: 3168-3175.
72. Shin, D. M., C. S. Yang, J. M. Yuk, J. Y. Lee, K. H. Kim. S. J. Shin, K. Takahara, S. J. Lee, and E. K. Jo. 2008. Mycobacterium abscessus activates the macrophage innate immune response via a physical and functional interaction between TLR2 and dectin-1. Cell Microbiol. 10: 1608-1621.